Translational Oncology
- Biomarker discovery
- Mouse clinical trial
- 61 PDX-derived primary cancer cell lines
- Drug-resistant xenograft models
- Combination therapy platform including radiation
- World leading genome sequencing and bioinformatics capability
translational Oncology 20200513
Related Content
At this year’s annual meeting of the American Association for Cancer Research (AACR), WuXi Biology has been selected to present...
VIEW RESOURCEWuXi Biology offers an integrated package of preclinical cancer pharmacology services for targeted oncology and immuno-oncology. Our platform includes in...
VIEW RESOURCE